about
Haploinsufficiency of TAB2 causes congenital heart defects in humansSomatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of boneMutational processes molding the genomes of 21 breast cancersORegAnno: an open-access community-driven resource for regulatory annotationTOUCAN 2: the all-inclusive open source workbench for regulatory sequence analysis.LRP1B deletion in high-grade serous ovarian cancers is associated with acquired chemotherapy resistance to liposomal doxorubicin.Genomic Classification and Prognosis in Acute Myeloid Leukemia.Mutational signatures associated with tobacco smoking in human cancerCombined hereditary and somatic mutations of replication error repair genes result in rapid onset of ultra-hypermutated cancersMutational signatures of ionizing radiation in second malignanciesTracing the origin of disseminated tumor cells in breast cancer using single-cell sequencingCollaboratively charting the gene-to-phenotype network of human congenital heart defectsThe landscape of cancer genes and mutational processes in breast cancerThe life history of 21 breast cancersSingle-cell paired-end genome sequencing reveals structural variation per cell cycle.ENDEAVOUR update: a web resource for gene prioritization in multiple speciesCopynumber: Efficient algorithms for single- and multi-track copy number segmentation.ascatNgs: Identifying Somatically Acquired Copy-Number Alterations from Whole-Genome Sequencing Data.Gene prioritization through genomic data fusion.Evidence for co-evolution between human microRNAs and Alu-repeatsComputational methods for the detection of cis-regulatory modules.Recurrent PTPRB and PLCG1 mutations in angiosarcoma.T-cell/histiocyte-rich large B-cell lymphoma shows transcriptional features suggestive of a tolerogenic host immune response.Recurrent mutation of IGF signalling genes and distinct patterns of genomic rearrangement in osteosarcoma.Landscape of somatic mutations in 560 breast cancer whole-genome sequences.Cleavage of NIK by the API2-MALT1 fusion oncoprotein leads to noncanonical NF-kappaB activationAllele-specific copy number analysis of tumors.Computational detection of cis -regulatory modules.Spatial and temporal diversity in genomic instability processes defines lung cancer evolution.Differential and limited expression of mutant alleles in multiple myeloma.EGFR gene variants are associated with specific somatic aberrations in glioma.Mobile DNA in cancer. Extensive transduction of nonrepetitive DNA mediated by L1 retrotransposition in cancer genomes.Analysis of the genetic phylogeny of multifocal prostate cancer identifies multiple independent clonal expansions in neoplastic and morphologically normal prostate tissue.Tracking the origins and drivers of subclonal metastatic expansion in prostate cancer.The evolutionary history of lethal metastatic prostate cancer.Canine Mammary Tumours Are Affected by Frequent Copy Number Aberrations, including Amplification of MYC and Loss of PTENTumor evolution. High burden and pervasive positive selection of somatic mutations in normal human skin.Integrated molecular profiles of invasive breast tumors and ductal carcinoma in situ (DCIS) reveal differential vascular and interleukin signalingMitotic recombination of chromosome arm 17q as a cause of loss of heterozygosity of NF1 in neurofibromatosis type 1-associated glomus tumors.
P50
Q24314581-577E6F90-C1D7-4466-98DE-1599B065D091Q24568313-108CDBD2-AEE7-450E-B746-0516EDF40103Q24595521-F713025C-80A2-4C31-A021-60BC603C6BFCQ24620915-BA1B6A4B-4CE3-47AB-ADB1-7B0C68CCF899Q24648942-C9150BB6-06FD-4A89-9272-B29696735809Q24812021-27A9E1CF-454A-4C00-BF20-C163A9634D18Q27851868-C1015CBB-D4FC-4731-A8E4-C9E1F9FF2426Q27853389-504A7434-DF0F-408E-8767-8C0701FCAE26Q28005544-7889929C-64C0-4425-960D-C2F46BCD0159Q28256331-9F9696A6-5027-4C4C-947F-7299E845DDF4Q28389573-75C9A3F4-BBCE-40E0-AAF1-D95A8FBF505DQ28396153-EFC90832-852C-4021-89EE-3C9AE6A65642Q28752037-32849B3A-98EC-4B93-B6BB-1824585688A4Q29614637-4D0B0620-E724-42CC-81FC-400C26424585Q29614642-78A2A0E9-4EEA-42F9-BC7C-CF7D53A85698Q30453107-3BE08D1D-0BB1-4EC2-8539-D61AC6156FBAQ30482616-C580242E-36F6-453E-9504-0FDAECF47358Q30536665-DB5BF601-8EA8-4A29-BA5C-0AF7F75DD572Q31147553-122A1521-CD6A-490C-99FB-DEE6650E2755Q33242612-2D65B86B-9313-4EBF-8583-CDDCFCCD9C91Q33408180-3C922EF0-3044-4EA5-B51A-3E9579DEEFFBQ33460920-EE909E8A-AE89-4771-A02F-54BA21CB095CQ33657848-9F799406-CED3-4652-827F-9572EEDFEE96Q33707435-BEA1F613-7D13-4E11-B038-FAF9D924A138Q33850534-E07E02BF-220E-4FA6-A6A5-2E13E204CCC9Q34046731-592AE9B0-80BB-4896-AC0E-A3C5CAE2B338Q34161140-4869412E-3AF4-4E39-9C4E-0C507AEB7BA0Q34165640-0F9867A3-FF7A-4D33-9123-1100A092171CQ34268462-D35D9625-4499-443B-AD00-9358846F6263Q34442770-9DA3BA2D-6C61-46A7-92EA-AA2CBEEB832AQ34508343-8E96DF44-0CD8-4A8E-9898-C227C81DEDD6Q34510228-5261FAED-165D-4F37-91CB-E171A811BDA6Q35234637-E61C4FE7-9139-48E0-9982-A978F64B6C77Q35235374-EF92F470-044C-4B16-9C9A-888FB977D1D7Q35407284-34F5346E-9CA2-4D49-A662-04788850C1C5Q35548366-E5F91D60-6B68-4222-9FFD-FD40A63ABBCEQ35587062-12E67741-14AF-420A-9396-952E36CF6902Q35752935-786ACC63-2D11-40B8-9E59-5EB6C5682115Q35779345-477941A0-025B-4B60-8A44-67E71BAB2ECAQ35809666-B27C2314-3884-4103-A27C-287E3C7C5D7E
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Peter Van Loo
@ast
Peter Van Loo
@en
Peter Van Loo
@es
Peter Van Loo
@nl
Peter Van Loo
@sl
type
label
Peter Van Loo
@ast
Peter Van Loo
@en
Peter Van Loo
@es
Peter Van Loo
@nl
Peter Van Loo
@sl
altLabel
Van Loo P
@en
prefLabel
Peter Van Loo
@ast
Peter Van Loo
@en
Peter Van Loo
@es
Peter Van Loo
@nl
Peter Van Loo
@sl
P106
P1153
8832430500
P21
P31
P496
0000-0003-0292-1949